Review
Open access
Sep 2026
Synaptic mitochondrial dysfunction and Alzheimer’s disease: from molecular mechanisms to therapeutic strategies
A organelle-centered perspective will clarify AD pathogenesis and help guide the development of next-generation neuroprotective therapies, and highlight the essential requirements for building one, centered on synaptic mitochondrial bioenergetics and quality control.
Yu-Xin Wang, Wei-Dong Wu, Li-Shuang Yan et al.
· Frontiers in Pharmacology · 0 citations